| 发明名称 |
DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS. |
| 摘要 |
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments. |
| 申请公布号 |
MX2016011105(A) |
申请公布日期 |
2016.12.12 |
| 申请号 |
MX20160011105 |
申请日期 |
2015.03.05 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
Wei MENG;Guohua ZHAO |
| 分类号 |
C07D401/14;A61K31/4418;A61K31/444;A61K31/506;C07D401/04;C07D409/04;C07D409/14;C07D417/14 |
主分类号 |
C07D401/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
